×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Akero Therapeutics Inc. (AKRO) NASDAQ

$25.26 0.81 (3.31%)

Market Cap: $1.38B

As of 03/28/24 04:00 PM EDT. Market closed.

(AKRO)

Akero Therapeutics Inc. (AKRO)
NASDAQ

$25.26
0.81 (3.31%)

Market Cap: $1.38B

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

akero therapeutics is developing best-in-class medicines that restore metabolic balance to treat non-alcoholic steatohepatitis (nash) and other serious metabolic diseases. akero's lead clinical program, akr-001, is a long-acting fc fusion modified fgf21 protein and potential best-in-class treatment for nash. akr-001 builds upon two decades of work on fgf21 biology. it is designed to affect both ... read more

akero therapeutics is developing best-in-class medicines that restore metabolic balance to treat non-alcoholic steatohepatitis (nash) and other serious metabolic diseases. akero's lead clinical program, akr-001, is a long-acting fc fusion modified fgf21 protein and potential best-in-class treatment for nash. akr-001 builds upon two decades of work on fgf21 biology. it is designed to affect both the liver and adipose tissue, reducing liver fat and suppressing inflammation and fibrosis. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
601 Gateway Boulevard, Suite 350, California, South San Francisco, 94080.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
39
Address
601 Gateway Boulevard, Suite 350, California, South San Francisco, 94080.
PRICE CHART FOR AKERO THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$24.22
Previous Close
$24.45
Days Range
$23.59 - $25
52 week range
$11.25 - $58.38
Volume
851,564
Avg. Volume (30 days)
2,322,821
Market Cap
$1.38B
Dividend Yield
-
P/E
-
Shares Outstanding
56,297,528
Open
$24.22
Previous Close
$24.45
Days Range
$23.59 - $25
52 week range
$11.25 - $58.38
Volume
851,564
Avg. Volume (30 days)
2,322,821
Market Cap
$1.38B
Dividend Yield
-
P/E
-
Shares Outstanding
56,297,528
FINANCIAL STATEMENTS FOR AKERO THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR AKERO THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Yale CatrionaChief Development OfficerMar 13, 2024 Sale$28.3372320,48377,692Mar 15, 2024, 04:45 PM
White William RichardChief Financial OfficerMar 13, 2024 Sale$28.3372420,51149,630Mar 15, 2024, 04:44 PM
Cheng AndrewPresident and CEOMar 13, 2024 Sale$28.331,96955,782589,447Mar 15, 2024, 04:43 PM
Young JonathanChief Operating OfficerMar 13, 2024 Sale$28.3365118,443268,306Mar 15, 2024, 04:42 PM
Rolph TimothyChief Scientific OfficerMar 13, 2024 Sale$28.3361917,536182,558Mar 15, 2024, 04:42 PM
Cheng AndrewPresident and CEOMar 04, 2024 Option Exercise$17.1775,0001,288,062666,416Mar 06, 2024, 08:14 PM
Cheng AndrewPresident and CEOMar 04, 2024 Sale$32.8775,0002,465,063630,589Mar 06, 2024, 08:14 PM
Yale CatrionaChief Development OfficerMar 04, 2024 Option Exercise$13.9620,646288,12499,061Mar 06, 2024, 08:13 PM
Yale CatrionaChief Development OfficerMar 04, 2024 Sale$35.4920,646732,72778,415Mar 06, 2024, 08:13 PM
Young JonathanChief Operating OfficerMar 01, 2024 Option Exercise$0.6283,32151,242268,957Mar 05, 2024, 05:16 PM
Young JonathanChief Operating OfficerDec 27, 2023 Option Exercise$6.365,41434,433190,545Dec 29, 2023, 08:30 PM
Young JonathanChief Operating OfficerDec 27, 2023 Sale$24.005,414129,936185,131Dec 29, 2023, 08:30 PM
Yale CatrionaChief Development OfficerDec 14, 2023 Sale$20.7659712,39477,910Dec 18, 2023, 08:49 PM
White William RichardChief Financial OfficerDec 14, 2023 Sale$20.7661112,68450,354Dec 18, 2023, 08:40 PM
Young JonathanChief Operating OfficerDec 14, 2023 Sale$20.7654311,273185,131Dec 18, 2023, 08:39 PM
Cheng AndrewPresident and CEODec 14, 2023 Sale$20.761,62833,797550,911Dec 18, 2023, 08:37 PM
Rolph TimothyChief Scientific OfficerDec 14, 2023 Sale$20.7651410,671182,672Dec 18, 2023, 08:29 PM
Graham G. WalmsleyDirectorDec 08, 2023 Buy$19.83100,0001,982,940800,000Dec 11, 2023, 09:06 PM
Cheng AndrewPresident and CEODec 07, 2023 Option Exercise$6.366,70042,612467,698Dec 11, 2023, 08:59 PM
Cheng AndrewPresident and CEODec 11, 2023 Option Exercise$6.367,40547,096559,944Dec 11, 2023, 08:59 PM
Cheng AndrewPresident and CEODec 08, 2023 Option Exercise$6.3612,87381,872473,871Dec 11, 2023, 08:59 PM
Cheng AndrewPresident and CEODec 11, 2023 Sale$20.027,405148,273552,539Dec 11, 2023, 08:59 PM
Cheng AndrewPresident and CEODec 08, 2023 Sale$20.0112,873257,571460,998Dec 11, 2023, 08:59 PM
Cheng AndrewPresident and CEODec 07, 2023 Sale$20.026,700134,125460,998Dec 11, 2023, 08:59 PM
Graham G. WalmsleyDirectorDec 01, 2023 Buy$16.9950,000849,730700,000Dec 05, 2023, 08:37 AM
Graham G. WalmsleyDirectorNov 30, 2023 Buy$16.9050,000844,835650,000Dec 05, 2023, 08:37 AM
Young JonathanChief Operating OfficerNov 17, 2023 Sale$14.6830,000440,259153,177Nov 21, 2023, 05:30 PM
Cheng AndrewPresident and CEOOct 02, 2023 Option Exercise$6.3625,000159,000485,998Oct 04, 2023, 08:41 PM
Cheng AndrewPresident and CEOOct 02, 2023 Sale$47.9125,0001,197,827477,130Oct 04, 2023, 08:41 PM
Young JonathanChief Operating OfficerOct 02, 2023 Option Exercise$21.1049010,339183,667Oct 04, 2023, 08:33 PM
Young JonathanChief Operating OfficerOct 02, 2023 Sale$51.1049025,039183,177Oct 04, 2023, 08:33 PM
Cheng AndrewPresident and CEOSep 13, 2023 Sale$50.341,68284,672460,998Sep 25, 2023, 08:36 PM
White William RichardChief Financial OfficerSep 13, 2023 Sale$50.3463231,81518,468Sep 25, 2023, 08:31 PM
Yale CatrionaChief Development OfficerSep 21, 2023 Option Exercise$6.365,00031,80051,010Sep 25, 2023, 08:31 PM
Yale CatrionaChief Development OfficerSep 21, 2023 Sale$48.075,000240,35648,210Sep 25, 2023, 08:31 PM
Yale CatrionaChief Development OfficerSep 13, 2023 Sale$50.3461731,06046,010Sep 25, 2023, 08:31 PM
Rolph TimothyChief Scientific OfficerSep 13, 2023 Sale$50.3453126,731150,689Sep 25, 2023, 08:30 PM
Young JonathanChief Operating OfficerSep 13, 2023 Sale$50.3456228,291183,177Sep 25, 2023, 08:28 PM
Cheng AndrewPresident and CEOSep 01, 2023 Option Exercise$6.3625,000159,000487,680Sep 18, 2023, 06:48 PM
Cheng AndrewPresident and CEOSep 01, 2023 Sale$49.7725,0001,244,248462,807Sep 18, 2023, 06:48 PM
Cheng AndrewPresident and CEOAug 30, 2023 Option Exercise$0.6215,0009,225462,680Aug 30, 2023, 07:04 PM
Yale CatrionaChief Development OfficerAug 28, 2023 Option Exercise$6.365,74536,53852,372Aug 30, 2023, 07:04 PM
Yale CatrionaChief Development OfficerAug 28, 2023 Sale$49.995,745287,19147,127Aug 30, 2023, 07:04 PM
Graham G. WalmsleyDirectorAug 08, 2023 Buy$42.0625,0001,051,475600,000Aug 10, 2023, 04:46 PM
Cheng AndrewPresident and CEOAug 01, 2023 Option Exercise$6.3625,000159,000472,680Aug 03, 2023, 04:13 PM
Cheng AndrewPresident and CEOAug 01, 2023 Sale$43.1525,0001,078,867459,001Aug 03, 2023, 04:13 PM
Graham G. WalmsleyDirectorAug 01, 2023 Buy$43.2625,0001,081,525575,000Aug 01, 2023, 07:52 PM
Graham G. WalmsleyDirectorJul 28, 2023 Buy$42.6930,0001,280,709550,000Aug 01, 2023, 07:52 PM
Cheng AndrewPresident and CEOJul 03, 2023 Option Exercise$6.3625,000159,000472,680Jul 06, 2023, 08:44 PM
Cheng AndrewPresident and CEOJul 03, 2023 Sale$44.8825,0001,122,041453,950Jul 06, 2023, 08:44 PM
Cheng AndrewPresident and CEOJun 27, 2023 Option Exercise$0.6240,00024,600447,680Jun 27, 2023, 07:12 PM
Yale CatrionaChief Development OfficerJun 23, 2023 Sale$50.7611,000558,36047,127Jun 23, 2023, 08:06 PM
Yale CatrionaChief Development OfficerJun 22, 2023 Sale$52.1811,000573,93557,627Jun 23, 2023, 08:06 PM
Yale CatrionaChief Development OfficerJun 21, 2023 Sale$52.2611,349593,09568,627Jun 23, 2023, 08:06 PM
White William RichardChief Financial OfficerJun 20, 2023 Option Exercise$7.0117,500122,65739,877Jun 22, 2023, 05:20 PM
White William RichardChief Financial OfficerJun 20, 2023 Sale$55.0020,7771,142,73519,100Jun 22, 2023, 05:20 PM
Heyman Tomas J.DirectorJun 16, 2023 Option Exercise$25.0426,000651,04026,000Jun 21, 2023, 05:54 PM
Heyman Tomas J.DirectorJun 16, 2023 Sale$54.6726,0001,421,5290Jun 21, 2023, 05:54 PM
Henderson JaneDirectorJun 16, 2023 Option Exercise$7.0140,000280,40040,000Jun 21, 2023, 05:47 PM
Henderson JaneDirectorJun 16, 2023 Sale$54.1740,0002,166,68522,498Jun 21, 2023, 05:47 PM
Rolph TimothyChief Scientific OfficerJun 16, 2023 Option Exercise$0.6140,00024,400229,420Jun 21, 2023, 05:46 PM
Rolph TimothyChief Scientific OfficerJun 16, 2023 Sale$54.7878,2004,284,066180,095Jun 21, 2023, 05:46 PM
White William RichardChief Financial OfficerJun 13, 2023 Sale$55.1660633,42722,377Jun 15, 2023, 09:41 PM
Cheng AndrewPresident & CEOJun 13, 2023 Sale$55.161,61388,973407,680Jun 15, 2023, 09:38 PM
Rolph TimothyChief Scientific OfficerJun 13, 2023 Sale$55.1650928,076189,420Jun 15, 2023, 09:35 PM
Young JonathanChief Operating OfficerJun 13, 2023 Sale$55.1653829,676183,739Jun 15, 2023, 09:35 PM
Yale CatrionaChief Development OfficerJun 13, 2023 Sale$55.1659132,60079,976Jun 15, 2023, 09:29 PM
Graham G. WalmsleyDirectorSep 19, 2022 Buy$26.00400,00010,400,000400,000Jun 15, 2023, 09:26 PM
Graham G. WalmsleyDirectorMay 19, 2023 Buy$42.00120,0005,040,000520,000Jun 15, 2023, 09:26 PM
Cheng AndrewPresident and CEOJun 01, 2023 Option Exercise$1.4625,00036,459434,293Jun 05, 2023, 06:23 PM
Cheng AndrewPresident and CEOJun 01, 2023 Sale$45.1025,0001,127,430430,379Jun 05, 2023, 06:23 PM
Graham G. WalmsleyDirectorMay 19, 2023 Buy$42.00120,0005,040,000520,000May 23, 2023, 09:55 PM
Graham G. WalmsleyDirectorSep 19, 2023 Buy$26.00400,00010,400,000400,000May 23, 2023, 09:55 PM
Cheng AndrewPresident & CEOMay 01, 2023 Option Exercise$0.6225,00015,375434,293May 03, 2023, 08:28 PM
Cheng AndrewPresident & CEOApr 18, 2023 Option Exercise$0.6240,00024,600409,293May 03, 2023, 08:28 PM
Cheng AndrewPresident & CEOMay 01, 2023 Sale$45.0725,0001,126,860412,770May 03, 2023, 08:28 PM
Cheng AndrewPresident & CEOApr 03, 2023 Option Exercise$0.6225,00015,375394,293Apr 05, 2023, 04:55 PM
Cheng AndrewPresident & CEOApr 03, 2023 Sale$37.9425,000948,576371,001Apr 05, 2023, 04:55 PM
White William RichardChief Financial OfficerMar 10, 2023 Option Exercise$43.4764127,86422,983Mar 14, 2023, 04:25 PM
Yale CatrionaChief Development OfficerMar 10, 2023 Option Exercise$43.4670130,46580,567Mar 14, 2023, 04:20 PM
Young JonathanChief Operating OfficerMar 10, 2023 Option Exercise$43.4763427,560184,277Mar 14, 2023, 04:19 PM
Rolph TimothyChief Scientific OfficerMar 10, 2023 Option Exercise$43.4760326,212189,929Mar 14, 2023, 04:19 PM
Cheng AndrewPresident & CEOMar 10, 2023 Option Exercise$43.471,70674,160369,293Mar 14, 2023, 04:18 PM
Cheng AndrewPresident & CEOFeb 01, 2023 Option Exercise$0.6225,00015,375395,999Feb 03, 2023, 05:25 PM
Cheng AndrewPresident & CEOFeb 01, 2023 Sale$49.0625,0001,226,395381,154Feb 03, 2023, 05:25 PM
Yale CatrionaChief Development OfficerJan 13, 2023 Sale$50.535,000252,65185,220Jan 18, 2023, 05:30 PM
Cheng AndrewPresident & CEOJan 03, 2023 Option Exercise$0.6225,00015,375395,999Jan 05, 2023, 06:46 PM
Cheng AndrewPresident & CEOJan 03, 2023 Sale$51.2725,0001,281,751382,799Jan 05, 2023, 06:46 PM
Young JonathanChief Operating OfficerJan 03, 2023 Option Exercise$0.628,7775,398193,688Jan 05, 2023, 05:56 PM
Young JonathanChief Operating OfficerJan 03, 2023 Sale$54.648,777479,560184,911Jan 05, 2023, 05:56 PM
Rolph TimothyChief Scientific OfficerDec 29, 2022 Option Exercise$28.357,816221,584210,848Dec 30, 2022, 04:26 PM
Rolph TimothyChief Scientific OfficerDec 28, 2022 Option Exercise$28.351,70048,195204,732Dec 30, 2022, 04:26 PM
Rolph TimothyChief Scientific OfficerDec 29, 2022 Sale$51.0520,3161,037,119202,825Dec 30, 2022, 04:26 PM
Rolph TimothyChief Scientific OfficerDec 28, 2022 Sale$50.001,70085,006203,032Dec 30, 2022, 04:26 PM
White William RichardChief Financial OfficerDec 28, 2022 Option Exercise$7.019997,00224,623Dec 29, 2022, 05:41 PM
White William RichardChief Financial OfficerDec 27, 2022 Option Exercise$7.0119,001133,17842,625Dec 29, 2022, 05:41 PM
White William RichardChief Financial OfficerDec 28, 2022 Sale$49.7699949,71423,624Dec 29, 2022, 05:41 PM
White William RichardChief Financial OfficerDec 27, 2022 Sale$49.7719,001945,60923,624Dec 29, 2022, 05:41 PM
Young JonathanChief Operating OfficerDec 27, 2022 Option Exercise$6.0312,50075,352194,949Dec 28, 2022, 06:30 PM
Young JonathanChief Operating OfficerDec 27, 2022 Sale$49.5712,500619,609182,449Dec 28, 2022, 06:30 PM
Cheng AndrewPresident & CEODec 16, 2022 Option Exercise$0.628,5005,228370,999Dec 20, 2022, 07:46 PM
Yale CatrionaChief Development OfficerDec 12, 2022 Sale$43.235,000216,13786,670Dec 13, 2022, 08:24 PM
Skorpios TrustFormer 10% ownerDec 01, 2022 Sale$43.501,636,00071,166,0003,271,829Dec 05, 2022, 04:36 PM
Cheng AndrewPresident & CEODec 01, 2022 Option Exercise$0.6210,0006,150320,148Dec 02, 2022, 05:52 PM
Cheng AndrewPresident & CEODec 01, 2022 Sale$46.0710,000460,700310,148Dec 02, 2022, 05:52 PM
Harrison Seth LoringDirectorNov 30, 2022 Sale$46.9412,030564,673153,242Dec 02, 2022, 05:48 PM
Harrison Seth LoringDirectorNov 30, 2022 Sale$46.9411,101521,067141,080Dec 02, 2022, 05:48 PM
Rolph TimothyChief Scientific OfficerNov 16, 2022 Sale$45.473,947179,464183,937Nov 16, 2022, 07:15 PM
Rolph TimothyChief Scientific OfficerNov 15, 2022 Sale$45.043,138141,343187,784Nov 16, 2022, 07:15 PM
Yale CatrionaChief Development OfficerNov 10, 2022 Sale$39.425,000197,10572,173Nov 14, 2022, 05:26 PM
Cheng AndrewPresident & CEONov 01, 2022 Option Exercise$0.6210,0006,150320,148Nov 02, 2022, 09:52 PM
Cheng AndrewPresident & CEONov 01, 2022 Sale$43.4210,000434,183319,548Nov 02, 2022, 09:52 PM
Harrison Seth LoringDirectorOct 28, 2022 Sale$40.3121,138852,091148,202Nov 01, 2022, 05:38 PM
Harrison Seth LoringDirectorOct 28, 2022 Sale$40.3122,965925,738160,962Nov 01, 2022, 05:38 PM
Harrison Seth LoringDirectorOct 27, 2022 Sale$41.5372,1722,997,575210,790Oct 27, 2022, 09:50 PM
Harrison Seth LoringDirectorOct 27, 2022 Sale$41.5366,4262,758,920194,063Oct 27, 2022, 09:50 PM
Harrison Seth LoringDirectorOct 26, 2022 Sale$43.7571,5833,131,402287,852Oct 27, 2022, 09:50 PM
Harrison Seth LoringDirectorOct 26, 2022 Sale$43.7565,8852,882,142264,991Oct 27, 2022, 09:50 PM
Harrison Seth LoringDirectorOct 25, 2022 Sale$44.924,906220,359326,813Oct 27, 2022, 09:50 PM
Harrison Seth LoringDirectorOct 25, 2022 Sale$44.924,515202,797300,851Oct 27, 2022, 09:50 PM
Rolph TimothyChief Scientific OfficerOct 25, 2022 Option Exercise$10.3110,000103,116206,337Oct 27, 2022, 09:27 PM
Rolph TimothyChief Scientific OfficerOct 26, 2022 Sale$45.034,762214,433190,922Oct 27, 2022, 09:27 PM
Rolph TimothyChief Scientific OfficerOct 25, 2022 Sale$45.0910,653480,349195,684Oct 27, 2022, 09:27 PM
Young JonathanChief Operating OfficerOct 25, 2022 Option Exercise$6.3612,50079,500175,754Oct 27, 2022, 09:25 PM
Young JonathanChief Operating OfficerOct 25, 2022 Sale$44.7212,500558,944163,254Oct 27, 2022, 09:25 PM
Rolph TimothyChief Scientific OfficerSep 13, 2022 Option Exercise$6.3610,00063,600256,337Oct 27, 2022, 09:23 PM
Rolph TimothyChief Scientific OfficerSep 13, 2022 Sale$29.1822,500656,550233,837Oct 27, 2022, 09:23 PM
White William RichardChief Financial OfficerOct 13, 2022 Option Exercise$7.0120,000140,18024,429Oct 17, 2022, 05:40 PM
White William RichardChief Financial OfficerOct 13, 2022 Sale$39.8220,000796,4004,429Oct 17, 2022, 05:40 PM
Yale CatrionaChief Development OfficerOct 10, 2022 Sale$37.995,000189,95077,073Oct 12, 2022, 04:59 PM
Rolph TimothyChief Scientific OfficerOct 06, 2022 Option Exercise$21.0910,000210,900208,837Oct 07, 2022, 06:00 PM
Rolph TimothyChief Scientific OfficerOct 06, 2022 Sale$39.2922,500884,025186,337Oct 07, 2022, 06:00 PM
Cheng AndrewPresident & CEOOct 03, 2022 Option Exercise$0.6210,0006,150320,148Oct 05, 2022, 08:55 AM
Cheng AndrewPresident & CEOOct 03, 2022 Sale$33.2310,000332,278315,598Oct 05, 2022, 08:55 AM
Rolph TimothyChief Scientific OfficerSep 30, 2022 Option Exercise$16.4320,000328,589243,837Oct 04, 2022, 08:57 PM
Rolph TimothyChief Scientific OfficerSep 30, 2022 Sale$32.7245,0001,472,400221,337Oct 04, 2022, 08:57 PM
Cheng AndrewPresident & CEOSep 13, 2022 Option Exercise$0.6260,00036,900370,148Sep 15, 2022, 07:59 PM
Cheng AndrewPresident & CEOSep 13, 2022 Sale$27.4260,0001,645,444353,352Sep 15, 2022, 07:59 PM
Yale CatrionaChief Development OfficerSep 13, 2022 Sale$27.4840,0001,099,22896,059Sep 15, 2022, 07:59 PM
White William RichardChief Financial OfficerSep 13, 2022 Option Exercise$7.0132,500227,79236,929Sep 15, 2022, 07:57 PM
White William RichardChief Financial OfficerSep 13, 2022 Sale$27.0332,500878,34118,009Sep 15, 2022, 07:57 PM
Rolph TimothyChief Scientific OfficerSep 13, 2022 Sale$29.1822,500656,550223,837Sep 15, 2022, 07:56 PM
Yale CatrionaChief Development OfficerJun 30, 2022 Option Exercise$8.031,1529,251122,073Sep 13, 2022, 09:15 PM
White William RichardChief Financial OfficerJun 30, 2022 Option Exercise$8.031,1529,2514,429Sep 13, 2022, 09:14 PM
Rolph TimothyChief Scientific OfficerJun 30, 2021 Option Exercise$21.091,00721,238245,185Sep 13, 2022, 09:14 PM
Rolph TimothyChief Scientific OfficerJun 30, 2022 Option Exercise$8.031,1529,251246,337Sep 13, 2022, 09:14 PM
Cheng AndrewPresident and CEOJun 30, 2022 Option Exercise$8.031,1529,251310,148Sep 13, 2022, 09:13 PM
Cheng AndrewPresident & CEOMar 01, 2022 Option Exercise$0.6210,0006,150318,996Mar 02, 2022, 08:40 PM
Cheng AndrewPresident & CEOMar 01, 2022 Sale$17.5910,000175,900308,996Mar 02, 2022, 08:40 PM
Cheng AndrewPresident & CEOFeb 01, 2022 Option Exercise$0.6210,0006,150318,996Feb 03, 2022, 07:12 PM
Cheng AndrewPresident & CEOFeb 01, 2022 Sale$17.5610,000175,600308,996Feb 03, 2022, 07:12 PM
White William RichardChief Financial OfficerJan 14, 2022 Option Exercise$7.019,70067,98712,977Jan 18, 2022, 09:48 PM
White William RichardChief Financial OfficerJan 14, 2022 Sale$22.039,700213,6913,277Jan 18, 2022, 09:48 PM
Cheng AndrewPresident & CEOJan 10, 2022 Option Exercise$0.6210,0006,150308,996Jan 11, 2022, 09:40 PM
Cheng AndrewPresident & CEOJan 10, 2021 Sale$19.5510,000195,500298,996Jan 11, 2022, 09:40 PM
Young JonathanChief Operating OfficerJan 07, 2022 Option Exercise$0.6227,74417,063163,254Jan 11, 2022, 04:40 PM
Cheng AndrewPresident & CEOJan 03, 2022 Option Exercise$0.6253,00032,595308,996Jan 04, 2022, 09:21 PM
White William RichardChief Financial OfficerDec 21, 2021 Option Exercise$7.011007013,377Dec 23, 2021, 09:03 PM
White William RichardChief Financial OfficerDec 21, 2021 Sale$22.001002,2003,277Dec 23, 2021, 09:03 PM
White William RichardChief Financial OfficerDec 17, 2021 Option Exercise$7.013,20022,4296,477Dec 20, 2021, 04:54 PM
White William RichardChief Financial OfficerDec 17, 2021 Sale$22.043,20070,5283,277Dec 20, 2021, 04:54 PM
Cheng AndrewPresident & CEODec 02, 2021 Sale$20.1817,500353,150255,996Dec 03, 2021, 05:20 PM
Young JonathanChief Operating OfficerNov 04, 2021 Sale$24.336,220151,333135,510Nov 05, 2021, 04:17 PM
Young JonathanChief Operating OfficerNov 03, 2021 Sale$24.2718,780455,791141,730Nov 05, 2021, 04:17 PM
Cheng AndrewPresident & CEONov 02, 2021 Sale$22.5717,500394,975273,496Nov 03, 2021, 04:16 PM
White William RichardChief Financial OfficerNov 01, 2021 Option Exercise$7.016,50045,5589,777Nov 03, 2021, 04:15 PM
White William RichardChief Financial OfficerNov 01, 2021 Sale$22.246,500144,5603,277Nov 03, 2021, 04:15 PM
Yale CatrionaChief Development OfficerOct 15, 2021 Sale$21.5912,500269,826121,021Oct 18, 2021, 04:21 PM
Cheng AndrewPresident & CEOOct 04, 2021 Sale$21.5417,500376,950290,996Oct 05, 2021, 04:11 PM
White William RichardChief Financial OfficerOct 01, 2021 Option Exercise$7.016,50045,5589,777Oct 05, 2021, 04:10 PM
White William RichardChief Financial OfficerOct 01, 2021 Sale$22.066,500143,3673,277Oct 05, 2021, 04:10 PM
Yale CatrionaChief Development OfficerSep 15, 2021 Sale$24.6912,500308,605135,421Sep 17, 2021, 04:05 PM
Young JonathanChief Operating OfficerSep 01, 2021 Sale$24.0412,500300,500160,510Sep 03, 2021, 04:38 PM
White William RichardChief Financial OfficerSep 01, 2021 Option Exercise$7.018,55959,99011,836Sep 03, 2021, 04:38 PM
White William RichardChief Financial OfficerSep 01, 2021 Sale$24.008,559205,4163,277Sep 03, 2021, 04:38 PM
Cheng AndrewPresident & CEOSep 02, 2021 Sale$23.8917,500418,075308,496Sep 03, 2021, 04:37 PM
Yale CatrionaChief Development OfficerAug 16, 2021 Sale$18.7910,000187,900145,921Aug 17, 2021, 09:15 PM
White William RichardChief Financial OfficerAug 02, 2021 Option Exercise$7.014,44131,1277,718Aug 04, 2021, 05:39 PM
White William RichardChief Financial OfficerAug 02, 2021 Sale$22.034,44197,8353,277Aug 04, 2021, 05:39 PM
Cheng AndrewPresident & CEOAug 03, 2021 Sale$20.8317,500364,577326,596Aug 04, 2021, 05:38 PM
Yale CatrionaChief Development OfficerJul 15, 2021 Sale$20.9010,000209,044155,921Jul 19, 2021, 04:43 PM
Young JonathanChief Operating OfficerJul 15, 2021 Option Exercise$0.629,0005,535173,010Jul 19, 2021, 04:43 PM
White William RichardChief Financial OfficerJul 06, 2021 Option Exercise$7.016,50045,5589,777Jul 08, 2021, 07:19 PM
White William RichardChief Financial OfficerJul 06, 2021 Sale$24.526,500159,3803,277Jul 08, 2021, 07:19 PM
Cheng AndrewPresident & CEOJul 02, 2021 Sale$24.7817,500433,650342,489Jul 06, 2021, 05:52 PM
Bitterman KevinDirectorJun 01, 2021 Sale$26.2817,489459,6110Jun 03, 2021, 08:07 PM
Young JonathanChief Operating OfficerApr 01, 2021 Sale$28.753,05587,828170,120Apr 05, 2021, 05:15 PM
White William RichardChief Financial OfficerApr 01, 2021 Option Exercise$7.0150,000350,50052,270Apr 05, 2021, 05:14 PM
White William RichardChief Financial OfficerApr 01, 2021 Sale$28.6450,0001,432,1663,419Apr 05, 2021, 05:14 PM
Young JonathanChief Operating OfficerMar 01, 2021 Sale$30.483,05593,112173,375Mar 02, 2021, 05:56 PM
Young JonathanChief Operating OfficerFeb 01, 2021 Sale$29.243,05589,321176,430Feb 02, 2021, 04:08 PM
Cheng AndrewPresident & CEOJan 07, 2021 Option Exercise$0.6220,00012,300362,989Jan 11, 2021, 07:57 PM
Young JonathanChief Operating OfficerJan 07, 2021 Option Exercise$0.627,5004,613189,285Jan 11, 2021, 07:54 PM
Young JonathanChief Operating OfficerJan 08, 2021 Sale$28.1210,000281,200179,285Jan 11, 2021, 07:54 PM
Young JonathanChief Operating OfficerJan 04, 2021 Sale$25.293,06077,399181,885Jan 06, 2021, 06:48 PM
Cheng AndrewPresident & CEODec 28, 2020 Option Exercise$0.627,4804,638342,989Dec 29, 2020, 04:53 PM
Cheng AndrewPresident & CEODec 21, 2020 Option Exercise$0.6210,5006,510335,509Dec 23, 2020, 04:19 PM
Young JonathanChief Operating OfficerJun 30, 2020 Option Exercise$17.071,24521,250184,845Dec 09, 2020, 08:53 PM
White William RichardChief Financial OfficerJun 30, 2020 Option Exercise$17.071,24521,2502,270Dec 09, 2020, 08:52 PM
Yale CatrionaChief Development OfficerJun 30, 2020 Option Exercise$17.071,24521,250164,914Dec 09, 2020, 08:50 PM
Rolph TimothyChief Scientific OfficerJun 30, 2020 Option Exercise$17.071,24521,250244,178Dec 09, 2020, 08:49 PM
Cheng AndrewChief Executive OfficerJun 30, 2020 Option Exercise$17.071,24521,250327,559Dec 09, 2020, 08:47 PM
Bitterman KevinDirectorOct 09, 2020 Sale$28.9313,000376,09011,780Oct 14, 2020, 04:54 PM
Apple Tree Partners IV, L.P.10% OwnerJul 10, 2020 Buy$36.00415,00014,940,0005,830,203Jul 14, 2020, 04:46 PM
Harrison Seth LoringDirectorJul 10, 2020 Buy$36.00415,00014,940,0005,830,203Jul 14, 2020, 04:45 PM
Versant Venture Capital VI, L.P.10% OwnerJan 09, 2020 Sale$20.2116,527334,0112,846,941Jul 10, 2020, 08:28 PM
Versant Venture Capital VI, L.P.10% OwnerJan 08, 2020 Sale$19.8022,368442,8862,863,468Jul 10, 2020, 08:28 PM
Versant Venture Capital VI, L.P.10% OwnerJan 07, 2020 Sale$20.0514,162283,9482,885,836Jul 10, 2020, 08:28 PM
Versant Venture Capital VI, L.P.10% OwnerJan 02, 2020 Sale$20.3615,852322,6853,645,633Jul 10, 2020, 08:28 PM
Versant Venture Capital VI, L.P.10% OwnerJan 06, 2020 Sale$19.5453,3921,043,1022,948,422Jul 10, 2020, 08:28 PM
Versant Venture Capital VI, L.P.10% OwnerJan 03, 2020 Sale$19.213,20061,4852,953,490Jul 10, 2020, 08:28 PM
venBio Global Strategic Fund II L.P.10% OwnerJul 06, 2020 Sale$33.834,603155,7213,033,552Jul 06, 2020, 07:00 PM
venBio Global Strategic Fund II L.P.10% OwnerJul 02, 2020 Sale$33.633,800127,8053,038,155Jul 06, 2020, 07:00 PM
venBio Global Strategic Fund II L.P.10% OwnerJul 01, 2020 Sale$34.45108,0643,723,0103,041,955Jul 06, 2020, 07:00 PM
Graham G. WalmsleyDirectorMar 30, 2020 Option Exercise$19.972,16843,2952,168Apr 01, 2020, 06:52 PM
Young JonathanChief Operating OfficerMar 13, 2020 Option Exercise$0.6211,1176,837183,600Mar 16, 2020, 05:51 PM
Rolph TimothyChief Scientific OfficerMar 12, 2020 Option Exercise$0.6150,02430,515242,933Mar 13, 2020, 07:04 PM
venBio Global Strategic Fund II L.P.10% OwnerMar 06, 2020 Sale$23.791,80042,8313,150,019Mar 06, 2020, 05:23 PM
venBio Global Strategic Fund II L.P.10% OwnerMar 05, 2020 Sale$23.538,500200,0113,151,819Mar 06, 2020, 05:23 PM
venBio Global Strategic Fund II L.P.10% OwnerMar 04, 2020 Sale$23.8135,650848,7663,160,319Mar 06, 2020, 05:23 PM
venBio Global Strategic Fund II L.P.10% OwnerMar 03, 2020 Sale$23.006,401147,1993,195,969Mar 03, 2020, 05:52 PM
venBio Global Strategic Fund II L.P.10% OwnerMar 02, 2020 Sale$23.0610,297237,4593,202,370Mar 03, 2020, 05:52 PM
venBio Global Strategic Fund II L.P.10% OwnerFeb 28, 2020 Sale$21.305,100108,6523,212,667Mar 03, 2020, 05:52 PM
venBio Global Strategic Fund II L.P.10% OwnerFeb 26, 2020 Sale$22.442,52356,6153,229,548Feb 27, 2020, 07:51 PM
venBio Global Strategic Fund II L.P.10% OwnerFeb 25, 2020 Sale$23.671,60037,8763,232,071Feb 27, 2020, 07:51 PM
venBio Global Strategic Fund II L.P.10% OwnerFeb 27, 2020 Sale$22.541,78140,1443,227,767Feb 27, 2020, 07:51 PM
venBio Global Strategic Fund II L.P.10% OwnerFeb 12, 2020 Sale$27.1461633,233,671Feb 12, 2020, 05:56 PM
venBio Global Strategic Fund II L.P.10% OwnerFeb 11, 2020 Sale$27.052,18459,0683,233,677Feb 12, 2020, 05:56 PM
venBio Global Strategic Fund II L.P.10% OwnerFeb 10, 2020 Sale$27.087,836212,1683,225,861Feb 12, 2020, 05:56 PM
venBio Global Strategic Fund II L.P.10% OwnerFeb 06, 2020 Sale$27.036,102164,9553,233,697Feb 10, 2020, 05:47 PM
venBio Global Strategic Fund II L.P.10% OwnerFeb 05, 2020 Sale$25.9928,608743,5483,239,799Feb 06, 2020, 04:06 PM
venBio Global Strategic Fund II L.P.10% OwnerFeb 04, 2020 Sale$25.6553,7311,378,1793,268,407Feb 06, 2020, 04:06 PM
Versant Venture Capital VI, L.P.10% OwnerJan 21, 2020 Sale$22.2025,940575,8613,110,547Jan 21, 2020, 09:57 PM
Versant Venture Capital VI, L.P.10% OwnerJan 17, 2020 Sale$20.0911,103223,0593,118,638Jan 21, 2020, 09:57 PM
Versant Venture Capital VI, L.P.10% OwnerJan 16, 2020 Sale$19.7222,489443,4833,129,741Jan 21, 2020, 09:57 PM
Versant Venture Capital VI, L.P.10% OwnerJan 14, 2020 Sale$20.0012,307246,1403,159,741Jan 15, 2020, 09:53 PM
Versant Venture Capital VI, L.P.10% OwnerJan 13, 2020 Sale$20.1611,676235,4453,172,131Jan 15, 2020, 09:53 PM
Versant Venture Capital VI, L.P.10% OwnerJan 10, 2020 Sale$20.1019,343388,7943,183,724Jan 15, 2020, 09:53 PM
Versant Venture Capital VI, L.P.10% OwnerJan 15, 2020 Sale$19.737,511148,1923,152,230Jan 15, 2020, 09:53 PM
venBio Global Strategic Fund II L.P.10% OwnerJan 13, 2020 Sale$20.23494,0009,993,6203,322,138Jan 14, 2020, 08:58 AM
Young JonathanChief Operating OfficerJan 10, 2020 Option Exercise$0.6238,90723,928232,483Jan 10, 2020, 07:39 PM
venBio Global Strategic Fund II L.P.10% OwnerJan 08, 2020 Sale$19.8615,677311,3553,816,138Jan 10, 2020, 04:06 PM
venBio Global Strategic Fund II L.P.10% OwnerJan 08, 2020 Sale$19.8615,677311,3553,816,138Jan 10, 2020, 04:06 PM
Versant Venture Capital VI, L.P.10% OwnerJan 09, 2020 Sale$20.2116,527334,0113,203,067Jan 09, 2020, 08:11 PM
Versant Venture Capital VI, L.P.10% OwnerJan 08, 2020 Sale$19.8022,368442,8863,219,594Jan 09, 2020, 08:11 PM
Versant Venture Capital VI, L.P.10% OwnerJan 07, 2020 Sale$20.0514,162283,9483,241,962Jan 09, 2020, 08:11 PM
venBio Global Strategic Fund II L.P.10% OwnerJan 07, 2020 Sale$20.1731,000625,1493,831,815Jan 08, 2020, 04:10 PM
venBio Global Strategic Fund II L.P.10% OwnerJan 06, 2020 Sale$19.6442,221829,3813,862,815Jan 08, 2020, 04:10 PM
Versant Venture Capital VI, L.P.10% OwnerJan 03, 2020 Sale$19.213,20061,4853,309,616Jan 06, 2020, 08:59 PM
Versant Venture Capital VI, L.P.10% OwnerJan 02, 2020 Sale$20.3615,852322,6854,001,759Jan 06, 2020, 08:59 PM
Versant Venture Capital VI, L.P.10% OwnerJan 06, 2020 Sale$19.5453,3921,043,1023,304,548Jan 06, 2020, 08:59 PM
venBio Global Strategic Fund II L.P.10% OwnerJan 03, 2020 Sale$19.3012,498241,2143,905,036Jan 06, 2020, 04:07 PM
venBio Global Strategic Fund II L.P.10% OwnerJan 02, 2020 Sale$19.9423,000458,5073,917,534Jan 06, 2020, 04:07 PM
Cheng AndrewPresident & CEODec 31, 2019 Option Exercise$18.871,02519,338326,314Jan 03, 2020, 06:16 PM
Yale CatrionaChief Development OfficerDec 31, 2019 Option Exercise$18.871,02519,338163,669Jan 03, 2020, 06:16 PM
White William RichardChief Financial OfficerDec 31, 2019 Option Exercise$18.871,02519,3381,025Jan 03, 2020, 06:15 PM
venBio Global Strategic Fund II L.P.10% OwnerDec 31, 2019 Sale$23.9614,324343,2593,940,534Jan 03, 2020, 12:00 AM
Versant Venture Capital VI, L.P.10% OwnerDec 31, 2019 Sale$23.4817,207404,0203,656,585Dec 31, 2019, 07:11 PM
Versant Venture Capital VI, L.P.10% OwnerDec 30, 2019 Sale$24.39338,9198,266,2343,673,792Dec 31, 2019, 07:11 PM
Versant Venture Capital VI, L.P.10% OwnerDec 27, 2019 Sale$22.5833,256750,9204,012,711Dec 31, 2019, 07:11 PM
Versant Venture Capital VI, L.P.10% OwnerDec 27, 2019 Sale$22.5833,256750,9204,012,711Dec 31, 2019, 06:05 PM
Versant Venture Capital VI, L.P.10% OwnerDec 31, 2019 Sale$23.4817,207404,0203,656,585Dec 31, 2019, 06:05 PM
Versant Venture Capital VI, L.P.10% OwnerDec 30, 2019 Sale$24.39338,9198,266,2343,673,792Dec 31, 2019, 06:05 PM
Versant Venture Capital VI, L.P.10% OwnerDec 26, 2019 Sale$22.4823,600530,5284,045,967Dec 26, 2019, 08:59 PM
Versant Venture Capital VI, L.P.10% OwnerDec 24, 2019 Sale$21.701,60534,8294,069,567Dec 26, 2019, 08:59 PM
Versant Venture Capital VI, L.P.10% OwnerDec 23, 2019 Sale$21.565,433117,1354,071,172Dec 26, 2019, 08:59 PM
Versant Venture Capital VI, L.P.10% OwnerDec 20, 2019 Sale$19.8018,582367,9244,076,605Dec 26, 2019, 08:59 PM
Versant Venture Capital VI, L.P.10% OwnerDec 17, 2019 Sale$19.587,651149,8074,097,207Dec 19, 2019, 09:30 PM
Versant Venture Capital VI, L.P.10% OwnerDec 18, 2019 Sale$19.502,02039,3904,095,187Dec 19, 2019, 09:30 PM
Bitterman KevinDirectorJun 24, 2019 Buy$16.00270,0004,320,000505,099Jun 25, 2019, 06:06 PM
Atlas Venture Fund XI, L.P.10% OwnerJun 24, 2019 Buy$16.00270,0004,320,000505,099Jun 25, 2019, 06:06 PM
Royston AaronDirectorJun 24, 2019 Buy$16.00250,0004,000,000250,000Jun 25, 2019, 06:05 PM
Versant Venture Capital VI, L.P.10% OwnerJun 24, 2019 Buy$16.00400,0006,400,0004,104,858Jun 25, 2019, 06:05 PM
Harrison Seth LoringDirectorJun 24, 2019 Buy$16.00900,00014,400,0005,415,203Jun 25, 2019, 06:05 PM
Apple Tree Partners IV, L.P.10% OwnerJun 24, 2019 Buy$16.00900,00014,400,0005,415,203Jun 25, 2019, 06:04 PM
venBio Global Strategic Fund II L.P.10% OwnerJun 24, 2019 Buy$16.00250,0004,000,000250,000Jun 25, 2019, 09:20 AM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Yale CatrionaChief Development Officer03/13/202420,483
White William RichardChief Financial Officer03/13/202420,511
Cheng AndrewPresident and CEO03/13/202455,782
Young JonathanChief Operating Officer03/13/202418,443
Rolph TimothyChief Scientific Officer03/13/202417,536
Cheng AndrewPresident and CEO03/04/20241,288,062
Cheng AndrewPresident and CEO03/04/20242,465,063
Yale CatrionaChief Development Officer03/04/2024288,124
Yale CatrionaChief Development Officer03/04/2024732,727
Young JonathanChief Operating Officer03/01/202451,242
Young JonathanChief Operating Officer12/27/202334,433
Young JonathanChief Operating Officer12/27/2023129,936
Yale CatrionaChief Development Officer12/14/202312,394
White William RichardChief Financial Officer12/14/202312,684
Young JonathanChief Operating Officer12/14/202311,273
Cheng AndrewPresident and CEO12/14/202333,797
Rolph TimothyChief Scientific Officer12/14/202310,671
Graham G. WalmsleyDirector12/08/20231,982,940
Cheng AndrewPresident and CEO12/07/202342,612
Cheng AndrewPresident and CEO12/11/202347,096
Cheng AndrewPresident and CEO12/08/202381,872
Cheng AndrewPresident and CEO12/11/2023148,273
Cheng AndrewPresident and CEO12/08/2023257,571
Cheng AndrewPresident and CEO12/07/2023134,125
Graham G. WalmsleyDirector12/01/2023849,730
Graham G. WalmsleyDirector11/30/2023844,835
Young JonathanChief Operating Officer11/17/2023440,259
Cheng AndrewPresident and CEO10/02/2023159,000
Cheng AndrewPresident and CEO10/02/20231,197,827
Young JonathanChief Operating Officer10/02/202310,339
Young JonathanChief Operating Officer10/02/202325,039
Cheng AndrewPresident and CEO09/13/202384,672
White William RichardChief Financial Officer09/13/202331,815
Yale CatrionaChief Development Officer09/21/202331,800
Yale CatrionaChief Development Officer09/21/2023240,356
Yale CatrionaChief Development Officer09/13/202331,060
Rolph TimothyChief Scientific Officer09/13/202326,731
Young JonathanChief Operating Officer09/13/202328,291
Cheng AndrewPresident and CEO09/01/2023159,000
Cheng AndrewPresident and CEO09/01/20231,244,248
Cheng AndrewPresident and CEO08/30/20239,225
Yale CatrionaChief Development Officer08/28/202336,538
Yale CatrionaChief Development Officer08/28/2023287,191
Graham G. WalmsleyDirector08/08/20231,051,475
Cheng AndrewPresident and CEO08/01/2023159,000
Cheng AndrewPresident and CEO08/01/20231,078,867
Graham G. WalmsleyDirector08/01/20231,081,525
Graham G. WalmsleyDirector07/28/20231,280,709
Cheng AndrewPresident and CEO07/03/2023159,000
Cheng AndrewPresident and CEO07/03/20231,122,041
Cheng AndrewPresident and CEO06/27/202324,600
Yale CatrionaChief Development Officer06/23/2023558,360
Yale CatrionaChief Development Officer06/22/2023573,935
Yale CatrionaChief Development Officer06/21/2023593,095
White William RichardChief Financial Officer06/20/2023122,657
White William RichardChief Financial Officer06/20/20231,142,735
Heyman Tomas J.Director06/16/2023651,040
Heyman Tomas J.Director06/16/20231,421,529
Henderson JaneDirector06/16/2023280,400
Henderson JaneDirector06/16/20232,166,685
Rolph TimothyChief Scientific Officer06/16/202324,400
Rolph TimothyChief Scientific Officer06/16/20234,284,066
White William RichardChief Financial Officer06/13/202333,427
Cheng AndrewPresident & CEO06/13/202388,973
Rolph TimothyChief Scientific Officer06/13/202328,076
Young JonathanChief Operating Officer06/13/202329,676
Yale CatrionaChief Development Officer06/13/202332,600
Graham G. WalmsleyDirector09/19/202210,400,000
Graham G. WalmsleyDirector05/19/20235,040,000
Cheng AndrewPresident and CEO06/01/202336,459
Cheng AndrewPresident and CEO06/01/20231,127,430
Graham G. WalmsleyDirector05/19/20235,040,000
Graham G. WalmsleyDirector09/19/202310,400,000
Cheng AndrewPresident & CEO05/01/202315,375
Cheng AndrewPresident & CEO04/18/202324,600
Cheng AndrewPresident & CEO05/01/20231,126,860
Cheng AndrewPresident & CEO04/03/202315,375
Cheng AndrewPresident & CEO04/03/2023948,576
White William RichardChief Financial Officer03/10/202327,864
Yale CatrionaChief Development Officer03/10/202330,465
Young JonathanChief Operating Officer03/10/202327,560
Rolph TimothyChief Scientific Officer03/10/202326,212
Cheng AndrewPresident & CEO03/10/202374,160
Cheng AndrewPresident & CEO02/01/202315,375
Cheng AndrewPresident & CEO02/01/20231,226,395
Yale CatrionaChief Development Officer01/13/2023252,651
Cheng AndrewPresident & CEO01/03/202315,375
Cheng AndrewPresident & CEO01/03/20231,281,751
Young JonathanChief Operating Officer01/03/20235,398
Young JonathanChief Operating Officer01/03/2023479,560
Rolph TimothyChief Scientific Officer12/29/2022221,584
Rolph TimothyChief Scientific Officer12/28/202248,195
Rolph TimothyChief Scientific Officer12/29/20221,037,119
Rolph TimothyChief Scientific Officer12/28/202285,006
White William RichardChief Financial Officer12/28/20227,002
White William RichardChief Financial Officer12/27/2022133,178
White William RichardChief Financial Officer12/28/202249,714
White William RichardChief Financial Officer12/27/2022945,609
Young JonathanChief Operating Officer12/27/202275,352
Young JonathanChief Operating Officer12/27/2022619,609
Cheng AndrewPresident & CEO12/16/20225,228
Yale CatrionaChief Development Officer12/12/2022216,137
Skorpios TrustFormer 10% owner12/01/202271,166,000
Cheng AndrewPresident & CEO12/01/20226,150
Cheng AndrewPresident & CEO12/01/2022460,700
Harrison Seth LoringDirector11/30/2022564,673
Harrison Seth LoringDirector11/30/2022521,067
Rolph TimothyChief Scientific Officer11/16/2022179,464
Rolph TimothyChief Scientific Officer11/15/2022141,343
Yale CatrionaChief Development Officer11/10/2022197,105
Cheng AndrewPresident & CEO11/01/20226,150
Cheng AndrewPresident & CEO11/01/2022434,183
Harrison Seth LoringDirector10/28/2022852,091
Harrison Seth LoringDirector10/28/2022925,738
Harrison Seth LoringDirector10/27/20222,997,575
Harrison Seth LoringDirector10/27/20222,758,920
Harrison Seth LoringDirector10/26/20223,131,402
Harrison Seth LoringDirector10/26/20222,882,142
Harrison Seth LoringDirector10/25/2022220,359
Harrison Seth LoringDirector10/25/2022202,797
Rolph TimothyChief Scientific Officer10/25/2022103,116
Rolph TimothyChief Scientific Officer10/26/2022214,433
Rolph TimothyChief Scientific Officer10/25/2022480,349
Young JonathanChief Operating Officer10/25/202279,500
Young JonathanChief Operating Officer10/25/2022558,944
Rolph TimothyChief Scientific Officer09/13/202263,600
Rolph TimothyChief Scientific Officer09/13/2022656,550
White William RichardChief Financial Officer10/13/2022140,180
White William RichardChief Financial Officer10/13/2022796,400
Yale CatrionaChief Development Officer10/10/2022189,950
Rolph TimothyChief Scientific Officer10/06/2022210,900
Rolph TimothyChief Scientific Officer10/06/2022884,025
Cheng AndrewPresident & CEO10/03/20226,150
Cheng AndrewPresident & CEO10/03/2022332,278
Rolph TimothyChief Scientific Officer09/30/2022328,589
Rolph TimothyChief Scientific Officer09/30/20221,472,400
Cheng AndrewPresident & CEO09/13/202236,900
Cheng AndrewPresident & CEO09/13/20221,645,444
Yale CatrionaChief Development Officer09/13/20221,099,228
White William RichardChief Financial Officer09/13/2022227,792
White William RichardChief Financial Officer09/13/2022878,341
Rolph TimothyChief Scientific Officer09/13/2022656,550
Yale CatrionaChief Development Officer06/30/20229,251
White William RichardChief Financial Officer06/30/20229,251
Rolph TimothyChief Scientific Officer06/30/202121,238
Rolph TimothyChief Scientific Officer06/30/20229,251
Cheng AndrewPresident and CEO06/30/20229,251
Cheng AndrewPresident & CEO03/01/20226,150
Cheng AndrewPresident & CEO03/01/2022175,900
Cheng AndrewPresident & CEO02/01/20226,150
Cheng AndrewPresident & CEO02/01/2022175,600
White William RichardChief Financial Officer01/14/202267,987
White William RichardChief Financial Officer01/14/2022213,691
Cheng AndrewPresident & CEO01/10/20226,150
Cheng AndrewPresident & CEO01/10/2021195,500
Young JonathanChief Operating Officer01/07/202217,063
Cheng AndrewPresident & CEO01/03/202232,595
White William RichardChief Financial Officer12/21/2021701
White William RichardChief Financial Officer12/21/20212,200
White William RichardChief Financial Officer12/17/202122,429
White William RichardChief Financial Officer12/17/202170,528
Cheng AndrewPresident & CEO12/02/2021353,150
Young JonathanChief Operating Officer11/04/2021151,333
Young JonathanChief Operating Officer11/03/2021455,791
Cheng AndrewPresident & CEO11/02/2021394,975
White William RichardChief Financial Officer11/01/202145,558
White William RichardChief Financial Officer11/01/2021144,560
Yale CatrionaChief Development Officer10/15/2021269,826
Cheng AndrewPresident & CEO10/04/2021376,950
White William RichardChief Financial Officer10/01/202145,558
White William RichardChief Financial Officer10/01/2021143,367
Yale CatrionaChief Development Officer09/15/2021308,605
Young JonathanChief Operating Officer09/01/2021300,500
White William RichardChief Financial Officer09/01/202159,990
White William RichardChief Financial Officer09/01/2021205,416
Cheng AndrewPresident & CEO09/02/2021418,075
Yale CatrionaChief Development Officer08/16/2021187,900
White William RichardChief Financial Officer08/02/202131,127
White William RichardChief Financial Officer08/02/202197,835
Cheng AndrewPresident & CEO08/03/2021364,577
Yale CatrionaChief Development Officer07/15/2021209,044
Young JonathanChief Operating Officer07/15/20215,535
White William RichardChief Financial Officer07/06/202145,558
White William RichardChief Financial Officer07/06/2021159,380
Cheng AndrewPresident & CEO07/02/2021433,650
Bitterman KevinDirector06/01/2021459,611
Young JonathanChief Operating Officer04/01/202187,828
White William RichardChief Financial Officer04/01/2021350,500
White William RichardChief Financial Officer04/01/20211,432,166
Young JonathanChief Operating Officer03/01/202193,112
Young JonathanChief Operating Officer02/01/202189,321
Cheng AndrewPresident & CEO01/07/202112,300
Young JonathanChief Operating Officer01/07/20214,613
Young JonathanChief Operating Officer01/08/2021281,200
Young JonathanChief Operating Officer01/04/202177,399
Cheng AndrewPresident & CEO12/28/20204,638
Cheng AndrewPresident & CEO12/21/20206,510
Young JonathanChief Operating Officer06/30/202021,250
White William RichardChief Financial Officer06/30/202021,250
Yale CatrionaChief Development Officer06/30/202021,250
Rolph TimothyChief Scientific Officer06/30/202021,250
Cheng AndrewChief Executive Officer06/30/202021,250
Bitterman KevinDirector10/09/2020376,090
Apple Tree Partners IV, L.P.10% Owner07/10/202014,940,000
Harrison Seth LoringDirector07/10/202014,940,000
Versant Venture Capital VI, L.P.10% Owner01/09/2020334,011
Versant Venture Capital VI, L.P.10% Owner01/08/2020442,886
Versant Venture Capital VI, L.P.10% Owner01/07/2020283,948
Versant Venture Capital VI, L.P.10% Owner01/02/2020322,685
Versant Venture Capital VI, L.P.10% Owner01/06/20201,043,102
Versant Venture Capital VI, L.P.10% Owner01/03/202061,485
venBio Global Strategic Fund II L.P.10% Owner07/06/2020155,721
venBio Global Strategic Fund II L.P.10% Owner07/02/2020127,805
venBio Global Strategic Fund II L.P.10% Owner07/01/20203,723,010
Graham G. WalmsleyDirector03/30/202043,295
Young JonathanChief Operating Officer03/13/20206,837
Rolph TimothyChief Scientific Officer03/12/202030,515
venBio Global Strategic Fund II L.P.10% Owner03/06/202042,831
venBio Global Strategic Fund II L.P.10% Owner03/05/2020200,011
venBio Global Strategic Fund II L.P.10% Owner03/04/2020848,766
venBio Global Strategic Fund II L.P.10% Owner03/03/2020147,199
venBio Global Strategic Fund II L.P.10% Owner03/02/2020237,459
venBio Global Strategic Fund II L.P.10% Owner02/28/2020108,652
venBio Global Strategic Fund II L.P.10% Owner02/26/202056,615
venBio Global Strategic Fund II L.P.10% Owner02/25/202037,876
venBio Global Strategic Fund II L.P.10% Owner02/27/202040,144
venBio Global Strategic Fund II L.P.10% Owner02/12/2020163
venBio Global Strategic Fund II L.P.10% Owner02/11/202059,068
venBio Global Strategic Fund II L.P.10% Owner02/10/2020212,168
venBio Global Strategic Fund II L.P.10% Owner02/06/2020164,955
venBio Global Strategic Fund II L.P.10% Owner02/05/2020743,548
venBio Global Strategic Fund II L.P.10% Owner02/04/20201,378,179
Versant Venture Capital VI, L.P.10% Owner01/21/2020575,861
Versant Venture Capital VI, L.P.10% Owner01/17/2020223,059
Versant Venture Capital VI, L.P.10% Owner01/16/2020443,483
Versant Venture Capital VI, L.P.10% Owner01/14/2020246,140
Versant Venture Capital VI, L.P.10% Owner01/13/2020235,445
Versant Venture Capital VI, L.P.10% Owner01/10/2020388,794
Versant Venture Capital VI, L.P.10% Owner01/15/2020148,192
venBio Global Strategic Fund II L.P.10% Owner01/13/20209,993,620
Young JonathanChief Operating Officer01/10/202023,928
venBio Global Strategic Fund II L.P.10% Owner01/08/2020311,355
venBio Global Strategic Fund II L.P.10% Owner01/08/2020311,355
Versant Venture Capital VI, L.P.10% Owner01/09/2020334,011
Versant Venture Capital VI, L.P.10% Owner01/08/2020442,886
Versant Venture Capital VI, L.P.10% Owner01/07/2020283,948
venBio Global Strategic Fund II L.P.10% Owner01/07/2020625,149
venBio Global Strategic Fund II L.P.10% Owner01/06/2020829,381
Versant Venture Capital VI, L.P.10% Owner01/03/202061,485
Versant Venture Capital VI, L.P.10% Owner01/02/2020322,685
Versant Venture Capital VI, L.P.10% Owner01/06/20201,043,102
venBio Global Strategic Fund II L.P.10% Owner01/03/2020241,214
venBio Global Strategic Fund II L.P.10% Owner01/02/2020458,507
Cheng AndrewPresident & CEO12/31/201919,338
Yale CatrionaChief Development Officer12/31/201919,338
White William RichardChief Financial Officer12/31/201919,338
venBio Global Strategic Fund II L.P.10% Owner12/31/2019343,259
Versant Venture Capital VI, L.P.10% Owner12/31/2019404,020
Versant Venture Capital VI, L.P.10% Owner12/30/20198,266,234
Versant Venture Capital VI, L.P.10% Owner12/27/2019750,920
Versant Venture Capital VI, L.P.10% Owner12/27/2019750,920
Versant Venture Capital VI, L.P.10% Owner12/31/2019404,020
Versant Venture Capital VI, L.P.10% Owner12/30/20198,266,234
Versant Venture Capital VI, L.P.10% Owner12/26/2019530,528
Versant Venture Capital VI, L.P.10% Owner12/24/201934,829
Versant Venture Capital VI, L.P.10% Owner12/23/2019117,135
Versant Venture Capital VI, L.P.10% Owner12/20/2019367,924
Versant Venture Capital VI, L.P.10% Owner12/17/2019149,807
Versant Venture Capital VI, L.P.10% Owner12/18/201939,390
Bitterman KevinDirector06/24/20194,320,000
Atlas Venture Fund XI, L.P.10% Owner06/24/20194,320,000
Royston AaronDirector06/24/20194,000,000
Versant Venture Capital VI, L.P.10% Owner06/24/20196,400,000
Harrison Seth LoringDirector06/24/201914,400,000
Apple Tree Partners IV, L.P.10% Owner06/24/201914,400,000
venBio Global Strategic Fund II L.P.10% Owner06/24/20194,000,000
Load More Insider Transactions
FUNDS WITH A POSITION IN AKERO THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.4,180,5070.00249%5.11%Other
BAKER BROS. ADVISORS LP2,368,3780.63%No changeOther
ADAGE CAPITAL PARTNERS GP, L.L.C.275,0000.01%-85.85%Other
YIHENG CAPITAL MANAGEMENT, L.P.1,923,6742.59%57.46%Other
GEODE CAPITAL MANAGEMENT, LLC1,166,2450.00285%5.7%Other
HOLOCENE ADVISORS, LP612,000 (Call)0.06%4.38%Growth At A Reasonable Price
ORBIMED ADVISORS LLC350,0000.38%ExitedOther
HHLR ADVISORS, LTD.273,0020.31%ExitedOther
D. E. SHAW & CO., INC.210,9600.0043%54.1%Other
BALYASNY ASSET MANAGEMENT L.P.198,2710.00869%404.72%Event Driven
CANDRIAM S.C.A.184,0000.03%84%Other
ALPS ADVISORS INC37,2320.00684%-9.21%Other
TUDOR INVESTMENT CORP ET AL31,8810.02%ExitedEvent Driven, Other
HOLOCENE ADVISORS, LP21,8730.00484%ExitedGrowth At A Reasonable Price
AQR CAPITAL MANAGEMENT LLC16,7670.00074%53.84%Other
FARALLON CAPITAL MANAGEMENT LLC4,0000.00095%ExitedEvent Driven, Value
CHANGE IN SHARES OUTSTANDING FOR AKERO THERAPEUTICS INC
STOCK BUYBACKS FOR AKERO THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.25%
1Q
12/31/2023
06/30/2023
7.49%
2Q
12/31/2023
03/31/2023
18.76%
3Q
12/31/2023
12/31/2022
43.01%
4Q
12/31/2023
09/30/2022
44.20%
5Q
12/31/2023
06/30/2022
57.57%
6Q
12/31/2023
03/31/2022
59.27%
7Q
12/31/2023
12/31/2021
59.81%
8Q
12/31/2023
09/30/2021
59.92%
9Q
12/31/2023
06/30/2021
60.14%
10Q
12/31/2023
03/31/2021
60.46%
11Q
12/31/2023
12/31/2020
60.63%
12Q
12/31/2023
09/30/2020
63.96%
13Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.25%
1Q
06/30/2023
7.49%
2Q
03/31/2023
18.76%
3Q
12/31/2022
43.01%
4Q
09/30/2022
44.20%
5Q
06/30/2022
57.57%
6Q
03/31/2022
59.27%
7Q
12/31/2021
59.81%
8Q
09/30/2021
59.92%
9Q
06/30/2021
60.14%
10Q
03/31/2021
60.46%
11Q
12/31/2020
60.63%
12Q
09/30/2020
63.96%
13Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR AKERO THERAPEUTICS INC
LOADING...